Aethlon Medical (AEMD) Stock Surges 60% Following SEC Filings
Aethlon Medical's stock skyrocketed 60% after the company filed two disclosures with the SEC. The first withdrawal of a December 2024 offering statement signaled financial stability, easing investor concerns over potential share dilution. Market sentiment improved as the company demonstrated it wouldn't pursue unfavorable capital raises under current conditions.
The second filing introduced uncertainty with an unspecified share offering from existing stockholders. While 1.55 million shares may enter circulation, Aethlon clarified it won't receive proceeds from these sales. This mixed news created volatility, with traders interpreting the withdrawal as bullish and the secondary offering as a potential overhang.